~0 spots leftby Apr 2025

Corticosteroid Injection for Knee Arthritis

(COSTI Trial)

AK
Overseen byAmir Khoshbin, MD, FRCS (C)
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Phase 1 & 2
Recruiting
Sponsor: Unity Health Toronto
Disqualifiers: Inflammatory arthritis, Cognitive impairment, others
No Placebo Group

Trial Summary

What is the purpose of this trial?

Through a triple-blinded randomized control trial, the primary purpose of this pilot study is to assess the efficacy of administering peri-operative contralateral corticosteroid injection in patients undergoing TKA. The secondary outcome was to assess the effect of contralateral corticosteroid injection on pain and functional outcomes of patients undergoing TKA.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What data supports the effectiveness of the drug corticosteroid injection for knee arthritis?

Corticosteroid injections have been used since the 1950s to quickly relieve symptoms of knee arthritis, especially during severe flare-ups, by reducing inflammation and pain. However, the benefits are often short-lived, and there is some concern about potential harm to the joint over time.12345

Is it safe to use corticosteroid injections for knee arthritis?

Corticosteroid injections for knee arthritis are generally considered safe, but they can have side effects like skin reactions, infections, and tendon issues. They may also increase the risk of needing knee surgery and can affect blood sugar levels, especially in people with diabetes.14678

How is the drug Contralateral Corticosteroid Injection different from other treatments for knee arthritis?

Contralateral Corticosteroid Injection involves injecting corticosteroids into the knee joint to reduce inflammation and pain, which is a common approach for managing knee arthritis. This treatment is unique because it focuses on the use of corticosteroids, which are often debated in terms of their effectiveness, dosage, and frequency compared to other options like hyaluronic acid injections or surgical interventions.145910

Research Team

AK

Amir Khoshbin, MD, FRCS (C)

Principal Investigator

Unity Health Toronto

Eligibility Criteria

This trial is for individuals with knee osteoarthritis who are scheduled for total knee replacement surgery. Participants should not have any known allergies to corticosteroids or bupivacaine, and must be willing to undergo the study procedures.

Inclusion Criteria

I am 18 years old or older.
I haven't had injections in the opposite knee within the last year.
I have pain in the opposite knee with a score over 4 out of 10.
See 5 more

Exclusion Criteria

Cognitive impairment (dementia, Alzheimer's, uncontrolled delirium) which will prevent patients from completing primary outcome measure or comply with follow-up requirements
I have had knee surgery, such as a total knee replacement or fracture repair.
I have had knee surgery before.
See 3 more

Trial Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive either a contralateral corticosteroid injection or a sham band-aid application during the peri-operative period for TKA

Peri-operative
1 visit (in-person)

Follow-up

Participants are monitored for pain, function, and quality of life using various outcome measures

1 year
4 visits (in-person) at 4, 8, 12 weeks and 1 year post-surgery

Treatment Details

Interventions

  • Contralateral Corticosteroid Injection (Corticosteroid)
Trial OverviewThe study tests if a corticosteroid injection in the opposite knee can help reduce pain and improve function after knee replacement surgery. It's a triple-blinded trial, meaning neither patients, doctors nor assessors know who receives the real treatment.
Participant Groups
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Group A - Corticosteroid InjectionExperimental Treatment1 Intervention
Corticosteroid injection - 80mg methylprednisolone (total volume 2ml) with 6 mL of 1% Bupivacaine without epinephrine (Total Volume 8 mL). The patient will be brought to the regional room where a fully licensed anaesthesiologist will perform standard of care anaesthesia followed by an ultrasound guided intra-articular knee injection with steroid AFTER the spinal neuraxial blockage has already been administered.
Group II: Group B - Band-Aid PlacementPlacebo Group1 Intervention
The patient will be brought to the regional room where a fellowship trained interventional pain/regional anaesthesiologist will perform standard of care anaesthesia followed by the application of a band-aid.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Unity Health Toronto

Lead Sponsor

Trials
572
Recruited
470,000+

Findings from Research

In a study of 3,822 patients with or at risk of knee osteoarthritis, those who received corticosteroid injections had a significantly higher risk of needing knee arthroplasty, with 31.3% undergoing surgery compared to only 5.0% of those who did not receive injections.
Each corticosteroid injection increased the absolute risk of knee arthroplasty by 9.4% over nine years, suggesting that these injections may harm the joint and accelerate the progression of osteoarthritis, leading to a recommendation for more conservative treatment approaches.
Intra-articular corticosteroid injections increase the risk of requiring knee arthroplasty.Wijn, SRW., Rovers, MM., van Tienen, TG., et al.[2020]
Local corticosteroid injections are generally safe and can effectively manage symptoms in conditions like rheumatoid arthritis and knee osteoarthritis, providing relief for up to three months in some cases.
While these injections can help with acute flare-ups and certain symptoms, they do not significantly prevent joint damage or erosive changes, and their use should complement other treatments like physical therapy and disease-modifying drugs.
Intra-articular corticosteroids. An updated assessment.Gray, RG., Gottlieb, NL.[2006]
In a study involving 60 patients undergoing bilateral total knee arthroplasty, the use of a multimodal cocktail injection with corticosteroids did not show significant differences in pain relief, motion range, or swelling compared to injections without corticosteroids.
The findings suggest that multimodal periarticular injections without corticosteroids can effectively manage postoperative pain and swelling, indicating that corticosteroids like betamethasone may not be necessary for optimal outcomes in this context.
Local Efficacy of Corticosteroids as an Adjuvant for Periarticular Cocktail Injection in Simultaneous Bilateral Total Knee Arthroplasty: A Prospective Randomized Double-Blind Controlled Trial.Peng, H., Wang, W., Lin, J., et al.[2021]

References

Intra-articular corticosteroid injections increase the risk of requiring knee arthroplasty. [2020]
Injectable corticosteroids in treatment of arthritis of the knee. [2022]
Intra-articular corticosteroids. An updated assessment. [2006]
Local Efficacy of Corticosteroids as an Adjuvant for Periarticular Cocktail Injection in Simultaneous Bilateral Total Knee Arthroplasty: A Prospective Randomized Double-Blind Controlled Trial. [2021]
Corticosteroid injection into the osteoarthritic knee: drug selection, dose, and injection frequency. [2012]
Effect of Intra-articular Ketorolac Versus Corticosteroid Injection for Knee Osteoarthritis: A Retrospective Comparative Study. [2022]
Complications Associated with Intra-Articular and Extra-Articular Corticosteroid Injections. [2021]
Intra-synovial corticosteroid injections in juvenile chronic arthritis--a review. [2020]
Current concepts on the use of corticosteroid injections for knee osteoarthritis. [2022]
The efficacy, accuracy and complications of corticosteroid injections of the knee joint. [2021]